FDA Clears Genentech&#39;s Tarceva For Lung Cancer
476212
On Thursday, biotechnology companies Genentech Inc. and OSI Pharmaceuticals Inc. said US regulators have approved their drug Tarceva for treating the most common form of lung cancer.
75723
Genentech appears to have resolved a dispute with ophthalmologists over use of  the companyâs drug Avastin   to treat eye diseases.
167936
Cancer-focused biotechnology firm Hana   Biosciences said on Wednesday the U.S. Food and Drug   Administration had accepted Zensana Oral Spray for review.
36374
The FDA has approved the drug letrozole for use in postmenopausal women with early breast cancer who have completed standard adjuvant tamoxifen therapy.
127464
The Food and Drug Administration has approved a new form of the widely used cancer drug Taxol that is easier to administer and avoids some side effects.
538265
U.S. regulators cleared a new  genetic test on Monday that helps predict tumor recurrence and  long-term survival in breast cancer patients with higher risk  of the cancer returning.
740280
The Food and Drug Administration approved a cancer drug made by pharmaceutical giant Eli Lilly and Co. to treat advanced non-small cell lung cancer in patients who have undergone chemotherapy.
649663
LOS ANGELES/NEW YORK  - The U.S. Food and Drug   Administration said on Wednesday it had approved Amgen Inc.'s   drug Vectibix for use in colon cancer patients whose tumors   have spread despite chemotherapy treatment.
494130
Genzyme Corp. announced Wednesday that its drug Clolar has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of children with difficult or relapsed acute lymphoblastic leukemia (ALL).
472983
OSI Pharmaceuticals Inc., which has placed its future hopes almost entirely on its flagship anti-cancer drug Tarceva, said yesterday the experimental medication slightly improved the length
225228
BOSTON (CBS.MW) - Shares of Genentech were halted on Monday as the company announced that its oncology drug Avastin had been shown to extend the lives of some patients stricken with advanced colorectal cancer.
86074
BELGRADE, Sep 11 (IPS) - Serbian health authorities have finally confirmed  what was long suspected -- the nation tops the list in Europe for  lung cancers.
485506
A Merck &amp; Co. Inc. drug received federal approval Friday to treat a slow-growing cancer that affects infection-fighting white blood cells. The Food and Drug Administration approved the drug, Zolinza, to treat advanced cases of cutaneous T-cell lymphoma, a rare cancer that's a form of non-Hodgkin's lymphoma. Roughly 20,000 Americans have the cancer, Merck said.
438480
Credit Suisse First Boston said that an announcement from Onyx Pharmaceuticals (nasdaq: ONXX - news - people ) is &quot;good news&quot; for Genentech (nyse: DNA - news - people ) and its Avastin treatment.
161433
The U.S. Food and Drug   Administration said on Wednesday it had approved Amgen Inc's   drug Vectibix for the treatment of advanced colon cancer.
237993
Cancer-focused biotechnology firm Hana  Biosciences said on Wednesday the U.S. Food and Drug  Administration had accepted Zensana Oral Spray for review.
263089
A Merck &amp; Co. Inc. drug received federal approval Friday to treat a slow-growing cancer that affects infection-fighting white blood cells.